Seeing Is Believing
Healthcare - Sector
KYMR is currently covered by 14 analysts with an average price target of $77.79. This is a potential upside of $16.94 (27.84%) from yesterday's end of day stock price of $60.85.
Kymera Therapeutics's activity chart (see below) currently has 145 price targets and 109 ratings on display. The stock rating distribution of KYMR is 83.87% BUY and 16.13% HOLD.
Analysts average stock forecasts to be materialized ratio is 77.43% with an average time for these price targets to be met of 252.75 days.
Highest price target for KYMR is $80, Lowest price target is $52, average price target is $66.33.
Most recent stock forecast was given by KALPIT PATEL from B. RILEY on 23-Oct-2025. First documented stock forecast 14-Sep-2020.
Currently out of the existing stock ratings of KYMR, 26 are a BUY (83.87%), 5 are a HOLD (16.13%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$80
$21.44 (36.61%)
$60
4 days ago
(23-Oct-2025)
8/10 (80%)
$21.44 (36.61%)
183
Buy
$80
$21.44 (36.61%)
$54
11 days ago
(16-Oct-2025)
7/9 (77.78%)
$20.17 (33.71%)
96
Buy
$68
$9.44 (16.12%)
$53
28 days ago
(29-Sep-2025)
4/5 (80%)
$11.4 (20.14%)
367
Buy
$70
$11.44 (19.54%)
$60
1 months 10 days ago
(17-Sep-2025)
7/10 (70%)
$18.84 (36.83%)
81
Buy
$60
$1.44 (2.46%)
$55
1 months 11 days ago
(16-Sep-2025)
2/2 (100%)
$11.88 (24.69%)
161
What is KYMR (Kymera Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KYMR (Kymera Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?
Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?
Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?